SD Biosensor에스디바이오센서
137310 · KOSPI · ₩137310 · 에스디바이오센서
₩6,280▲ ₩20 (0.32%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩711B | ₩695B | ₩656B | ₩2.9T | ₩2.9T |
| Cost of sales | ₩385B | ₩355B | ₩530B | ₩1.5T | ₩1.4T |
| Gross profit | ₩326B | ₩339B | ₩126B | ₩1.4T | ₩1.6T |
| Operating income | −₩81B | −₩54B | −₩248B | ₩1.1T | ₩1.4T |
| Net income | −₩513B | −₩98B | −₩468B | ₩909B | ₩1.1T |
| Net income to shareholders | −₩512B | −₩98B | −₩468B | ₩911B | ₩1.1T |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩3.2T | ₩3.9T | ₩3.8T | ₩3.3T | ₩3T |
| Current assets | ₩1.2T | ₩938B | ₩965B | ₩2.5T | ₩2.6T |
| Cash and equivalents | ₩367B | ₩177B | ₩482B | ₩1.9T | ₩882B |
| Total liabilities | ₩906B | ₩956B | ₩957B | ₩315B | ₩802B |
| Current liabilities | ₩466B | ₩177B | ₩321B | ₩297B | ₩780B |
| Borrowings | ₩652B | ₩586B | ₩591B | ₩450M | ₩32B |
| Total equity | ₩2.3T | ₩2.9T | ₩2.8T | ₩2.9T | ₩2.2T |
| Shareholders' equity | ₩2.3T | ₩2.9T | ₩2.8T | ₩2.9T | ₩2.2T |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩358B | ₩157B | −₩242B | ₩890B | ₩1.2T |
| Capital spending | ₩57B | ₩79B | ₩143B | ₩297B | ₩97B |
| Free cash flow | ₩300B | ₩78B | −₩385B | ₩593B | ₩1.1T |
| Dividends paid | ₩24B | ₩38M | ₩30B | ₩199B | ₩50B |
Consolidated where available. Amounts in won.
Also known as: SD Biosensor / 에스디바이오센서 / 137310 / KRX:137310
Source: KRX statistical information